Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma
source: pixabay.com

Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma

  Currently, an estimated 47-50% of global nasopharyngeal carcinoma cases occur in China, with the regions of Guangdong, Guangxi and Fujian being heavily affected. There are a number of treatment…

Continue Reading Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma
Study of the Week: Chinese Herbal Medicine Increases the Effect of Radiotherapy for Nasopharyngeal Carcinoma
source: pixabay.com

Study of the Week: Chinese Herbal Medicine Increases the Effect of Radiotherapy for Nasopharyngeal Carcinoma

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Chinese Herbal Medicine Increases the Effect of Radiotherapy for Nasopharyngeal Carcinoma
For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups
ckstockphoto / Pixabay

For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups

  According to a recent article, a study shows the risk of getting nasopharyngeal carcinoma (NPC) varies considerably in different ethnic groups among Asian Americans. Nasopharyngeal Carcinoma (NPC) Nasopharyngeal carcinoma…

Continue Reading For Asian Americans the Risk of Developing Nasopharyngeal Carcinoma Varies Amongst Different Ethnic Groups

Combination Therapy Could Be New Nasopharyngeal Carcinoma Standard of Care

A recent Phase 3 clinical trial published in Lancet Oncology has identified that camrelizumab used in combination with gemcitabine and cisplatin (chemotherapy) improves progression-free survival (PFS) for those diagnosed with recurrent or…

Continue Reading Combination Therapy Could Be New Nasopharyngeal Carcinoma Standard of Care